
AI-generated summary
Myoma is a benign tumor of the uterus, which, if large, can cause severe pain and complications. In this case, the tumor weighed eight kilograms and was the size of a soccer ball.
Doctors at Vladivostok Clinical Hospital No. 1 removed a fibroid weighing eight kilograms from a patient.
The tumor had been developing for a long time, and doctors note that delaying the operation could lead to oncology.
The patient feels well and has already been discharged home.
VLADIVOSTOK, September 30 - RIA Novosti. Doctors removed an eight-kilogram fibroid the size of a soccer ball from a resident of Vladivostok, reports the Ministry of Health of Primorye.
“Eight kilograms - that’s how much the tumor weighed, with which the resident of the regional capital was urgently taken to Vladivostok Clinical Hospital No. 1. Due to severe pain, the woman could hardly speak. A complex operation to remove fibroids the size of a football was successfully carried out by the head of the gynecology department Inessa Stuzhina and doctor Tatyana Budennaya,” the message says.
It is noted that the tumor has been developing for a long time. During attacks of pain, the patient took painkillers and constantly postponed visiting the doctor. Doctors note that if she had to endure the pain again, the rapidly growing tumor could lead to cancer.
The patient is now feeling well and has already been discharged home. She has planned follow-up with a gynecologist and regular medical examinations ahead.

Academician of the Russian Academy of Sciences and Deputy President of the Russian Academy of Sciences Gennady Onishchenko said in an interview with RIA Novosti that a new dangerous strain of influenza may appear before 2029 due to the constant mutation of viruses, but emphasized that the modern healthcare system is capable of developing vaccines a year before the emergence of new infections, which will create global immunity.

General practitioner Alina Azizova said that people with diabetes, reduced immune defense, elderly Russians, young children, pregnant women and patients with chronic diseases of the respiratory system and cardiovascular system are at risk of severe respiratory infections. She emphasized the importance of vaccination against influenza, pneumococcal and Haemophilus influenzae type B, and also recommended avoiding close contact with sick people, using PPE, washing hands and ventilating rooms. In the first three weeks of September 2026, the number of calls for colds in Russia was one and a half times higher than in August.

US residents Natalie and Josh Strong filed a lawsuit against the Brown Fertility clinic, claiming that doctors accidentally used sperm from an unknown donor during fertilization, which led to the birth of a girl whose DNA does not match the DNA of the father. The couple discovered the discrepancy through a blood group analysis: the mother’s first was negative, the father’s second was negative, and the child’s third was positive. The clinic has not yet responded to the claims.

The Commissioner for Human Rights in the Russian Federation, Yana Lantratova, stated that the waiting time for an appointment with a therapist, pediatrician or general practitioner under compulsory medical insurance should not exceed 24 hours, emergency care in a clinic - no later than two hours, consultation with a specialist - within 14 working days.

General practitioner Alina Azizova from the SberHealth company warned that people with diabetes, weakened immunity and elderly Russians are at risk of severe respiratory infections. She emphasized the importance of annual vaccination against influenza, pneumococcal and Haemophilus influenzae type b, as well as adherence to general preventive measures: avoiding contact with sick people, wearing masks, ventilation and wet cleaning. According to the company, the seasonal increase in requests for colds in September 2026 has already begun and is one and a half times higher than August.

The Russian government is considering a draft order to include new drugs in the list of vital and essential drugs, including Arogleptol for type 2 diabetes and Verenafusp alfa for a hereditary metabolic disease, which will lead to state regulation of prices and control of trade markups.